Boris Radeleff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Boris Radeleff has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Goetz M. Richter
3 shared publicationsRuben Lopez-Benitez
3 shared publicationsChristof-Matthias Sommer
University of Heidelberg Medical Center
2 shared publications- Frank Bergmann
Institute of Pathology, University of Heidelberg, Heidelberg, Germany
2 shared publications G. Noeldge
2 shared publicationsG.M. Richter
2 shared publications
Latest Publications
- 2 September 2015
- Published by Georg Thieme Verlag KG in Gastroenterologie up2date
- Vol. 11 (03) , 153-155
Primäres hepatozellulär-neuroendokrin mischdifferenziertes Karzinom der Leber
1 Pathologisches Institut, Universitätsklinikum Heidelberg 2 Medizinische Klinik, Innere Medizin IV: Gastroenterologie, Infektionskrankheiten, Vergiftungen, Universitätsklinikum Heidelberg 3 Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Heidelberg 4 Radiologische Klinik, Abteilung Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg 5 Radiologische Klinik und Poliklinik Universitätsklinikum Heidelberg, Abteilung Nuklearmedizin
- 2 September 2015
- Published by Georg Thieme Verlag KG in Gastroenterologie up2date
- Vol. 11 (03) , 153-155
Primäres hepatozellulär-neuroendokrin mischdifferenziertes Karzinom der Leber
1 Pathologisches Institut, Universitätsklinikum Heidelberg 2 Medizinische Klinik, Innere Medizin IV: Gastroenterologie, Infektionskrankheiten, Vergiftungen, Universitätsklinikum Heidelberg 3 Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Heidelberg 4 Radiologische Klinik, Abteilung Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg 5 Radiologische Klinik und Poliklinik Universitätsklinikum Heidelberg, Abteilung Nuklearmedizin
- 1 April 2015
- Vol. 38 (2) , 494-7
Endovascular repair of a complex splenic artery aneurysm using a multilayer stent.
- 1 April 2015
- Vol. 38 (2) , 494-7
Endovascular repair of a complex splenic artery aneurysm using a multilayer stent.
- 1 November 2014
- Published by Elsevier in Pancreatology
- Vol. 14 (6) , 546-549
Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: A case report of chemosaturation with high-dose melphalan
- 1 November 2014
- Published by Elsevier in Pancreatology
- Vol. 14 (6) , 546-549
Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: A case report of chemosaturation with high-dose melphalan
- 7 May 2011
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 34 (5) , 1085-1089
Successful Thrombolysis and Spasmolysis of Acute Leg Ischemia after Accidental Intra-arterial Injection of Dissolved Flunitrazepam Tablets
A 37-year-old man with known intravenous drug abuse presented in the surgical ambulatory care unit with acute leg ischemia after accidental intra-arterial injection of dissolved flunitrazepam tablets into the right femoral artery. A combination of anticoagulation, vasodilatation, and local selective and superselective thrombolysis with urokinase was performed to salvage the leg. As a result of the severe ischemia-induced pain, the patient had to be monitored over the complete therapy period on the intensive care unit with permanent administration of intravenous fluid and analgetics. We describe the presenting symptoms and the interventional technique, and we discuss the recent literature regarding the management of accidental intra-arterial injection of dissolved flunitrazepam tablets.
- 7 May 2011
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 34 (5) , 1085-1089
Successful Thrombolysis and Spasmolysis of Acute Leg Ischemia after Accidental Intra-arterial Injection of Dissolved Flunitrazepam Tablets
A 37-year-old man with known intravenous drug abuse presented in the surgical ambulatory care unit with acute leg ischemia after accidental intra-arterial injection of dissolved flunitrazepam tablets into the right femoral artery. A combination of anticoagulation, vasodilatation, and local selective and superselective thrombolysis with urokinase was performed to salvage the leg. As a result of the severe ischemia-induced pain, the patient had to be monitored over the complete therapy period on the intensive care unit with permanent administration of intravenous fluid and analgetics. We describe the presenting symptoms and the interventional technique, and we discuss the recent literature regarding the management of accidental intra-arterial injection of dissolved flunitrazepam tablets.
- 31 October 2010
- Published by Elsevier in Academic Radiology
- Vol. 17 (10) , 1282-1287
Navigated Liver Biopsy Using a Novel Soft Tissue Navigation System versus CT-Guided Liver Biopsy in a Porcine Model: A Prospective Randomized Trial
- 31 October 2010
- Published by Elsevier in Academic Radiology
- Vol. 17 (10) , 1282-1287
Navigated Liver Biopsy Using a Novel Soft Tissue Navigation System versus CT-Guided Liver Biopsy in a Porcine Model: A Prospective Randomized Trial
- 1 July 2009
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 20 (7) , 927-935
Comparison of a Microporous Thermoplastic Polyurethane–covered Stent with a Self-expanding Bare Nitinol Stent in a Porcine Iliac Artery Model
- 1 July 2009
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 20 (7) , 927-935
Comparison of a Microporous Thermoplastic Polyurethane–covered Stent with a Self-expanding Bare Nitinol Stent in a Porcine Iliac Artery Model
- 2 October 2008
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 32 (1) , 32-37
Acute Increase in Hepatic Arterial Flow During TIPS Identified by Intravascular Flow Measurements
The purpose of this study was to investigate alterations of hepatic arterial flow during transjugular intrahepatic portosystemic stent shunt (TIPS) applying intravascular Doppler sonography. This prospective monocenter study included 25 patients with liver cirrhosis (alcohol induced [n = 19], chronic hepatitis associated [n = 3], primary biliary cirrhosis associated [n = 1], and cryptogenic [n = 2]) successfully treated with TIPS. All patients underwent intravascular hepatic arterial flow measurements during TIPS using an endoluminal flow sensor. The average arterial peak velocity (APV) and the maximum arterial peak velocity (MPV) were registered. Twenty-two patients (88%) showed increased APV, one patient (4%) showed unaffected APV, and two patients (8%) showed decreased APV after TIPS. The average portosystemic pressure gradient decreased significantly, from 22.0 ± 5.1 mmHg before TIPS to 11.0 ± 4.1 mmHg after TIPS (−50.0%; p < 0.0001). The average APV increased significantly, from 41.9 ± 17.8 cm/s before TIPS to 60.7 ± 19.0 cm/s after TIPS (+44.9%; p < 0.0001). The average MPV increased significantly, from 90.8 ± 31.7 cm/s before TIPS to 112.6 ± 34.9 cm/s after TIPS (+24.0%; p = 0.0002). These changes in perfusion set in within seconds after TIPS tract formation in all the patients with increased APV. We conclude that TIPS-induced portosystemic decompression leads to a significant increase in hepatic arterial flow. The changes occurred within seconds, suggesting a reflex-like mechanism.
- 2 October 2008
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 32 (1) , 32-37
Acute Increase in Hepatic Arterial Flow During TIPS Identified by Intravascular Flow Measurements
The purpose of this study was to investigate alterations of hepatic arterial flow during transjugular intrahepatic portosystemic stent shunt (TIPS) applying intravascular Doppler sonography. This prospective monocenter study included 25 patients with liver cirrhosis (alcohol induced [n = 19], chronic hepatitis associated [n = 3], primary biliary cirrhosis associated [n = 1], and cryptogenic [n = 2]) successfully treated with TIPS. All patients underwent intravascular hepatic arterial flow measurements during TIPS using an endoluminal flow sensor. The average arterial peak velocity (APV) and the maximum arterial peak velocity (MPV) were registered. Twenty-two patients (88%) showed increased APV, one patient (4%) showed unaffected APV, and two patients (8%) showed decreased APV after TIPS. The average portosystemic pressure gradient decreased significantly, from 22.0 ± 5.1 mmHg before TIPS to 11.0 ± 4.1 mmHg after TIPS (−50.0%; p < 0.0001). The average APV increased significantly, from 41.9 ± 17.8 cm/s before TIPS to 60.7 ± 19.0 cm/s after TIPS (+44.9%; p < 0.0001). The average MPV increased significantly, from 90.8 ± 31.7 cm/s before TIPS to 112.6 ± 34.9 cm/s after TIPS (+24.0%; p = 0.0002). These changes in perfusion set in within seconds after TIPS tract formation in all the patients with increased APV. We conclude that TIPS-induced portosystemic decompression leads to a significant increase in hepatic arterial flow. The changes occurred within seconds, suggesting a reflex-like mechanism.
- 25 February 2008
- Published by S. Karger AG in Digestive Surgery
- Vol. 25 (1) , 52-59
Efficacy and Safety of Percutaneous Transhepatic Portal Embolization before Right Liver Resection Using an Ethibloc/Lipiodol Mixture: A Single-Center Experience
Aim: The purpose of this study was to evaluate the safety and efficacy of percutaneous transhepatic portal vein embolization of the right portal vein with an Ethibloc/Lipiodol mixture to induce hypertrophy of the left liver lobe in patients with primarily unresectable liver tumor. Methods: 15 patients (8 primary liver tumors, 7 liver metastases) underwent portal vein embolization. Liver volumetry, duration of hospitalization, complication rates, relevant laboratory values were documented. Results: In 13/15 patients (84.6%) embolization could be performed with a median of 8.8 ml (range 1.5–28 ml) Ethibloc/Lipiodol. One minor procedure-related complication (subcapsular hematoma) occurred, which did not affect the two-step liver resection. No patient developed acute liver failure after embolization or liver resection. The volume of the left liver lobe increased significantly (p = 0.0015) by 25% from a median of 750 ml (587–1,114 ml) to 967 ml (597–1,249 ml). 11/13 (81.8%) of the embolized patients underwent liver resection at a median of 49 days after embolization. Median hospitalization time was 4 days after embolization and 7 days after liver resection. Median overall survival of the 11 operated patients was 376 days. Conclusion: Percutaneous transhepatic portal vein embolization using an Ethibloc/Lipiodol mixture is a safe, feasible, and efficient interventional procedure.
- 25 February 2008
- Published by S. Karger AG in Digestive Surgery
- Vol. 25 (1) , 52-59
Efficacy and Safety of Percutaneous Transhepatic Portal Embolization before Right Liver Resection Using an Ethibloc/Lipiodol Mixture: A Single-Center Experience
Aim: The purpose of this study was to evaluate the safety and efficacy of percutaneous transhepatic portal vein embolization of the right portal vein with an Ethibloc/Lipiodol mixture to induce hypertrophy of the left liver lobe in patients with primarily unresectable liver tumor. Methods: 15 patients (8 primary liver tumors, 7 liver metastases) underwent portal vein embolization. Liver volumetry, duration of hospitalization, complication rates, relevant laboratory values were documented. Results: In 13/15 patients (84.6%) embolization could be performed with a median of 8.8 ml (range 1.5–28 ml) Ethibloc/Lipiodol. One minor procedure-related complication (subcapsular hematoma) occurred, which did not affect the two-step liver resection. No patient developed acute liver failure after embolization or liver resection. The volume of the left liver lobe increased significantly (p = 0.0015) by 25% from a median of 750 ml (587–1,114 ml) to 967 ml (597–1,249 ml). 11/13 (81.8%) of the embolized patients underwent liver resection at a median of 49 days after embolization. Median hospitalization time was 4 days after embolization and 7 days after liver resection. Median overall survival of the 11 operated patients was 376 days. Conclusion: Percutaneous transhepatic portal vein embolization using an Ethibloc/Lipiodol mixture is a safe, feasible, and efficient interventional procedure.
- 24 October 2007
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 31 (1) , 209-214
Acute Liver Failure After a Late TIPSS Revision
We report a rare case of late transjugular intrahepatic portosystemic stent shunt (TIPSS) occlusion due to progressive stent protrusion into the periportal liver parenchyma, which was a result of delayed liver shrinkage 2 years after TIPSS. The initial TIPSS procedure had been carried out in a 52-year-old man as a bridge for liver transplantation because of post-alcoholic liver cirrhosis. We describe the applied TIPSS recanalization and revision technique. Immediately after TIPSS revision acute liver failure developed, which required emergency liver transplantation.
- 24 October 2007
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 31 (1) , 209-214
Acute Liver Failure After a Late TIPSS Revision
We report a rare case of late transjugular intrahepatic portosystemic stent shunt (TIPSS) occlusion due to progressive stent protrusion into the periportal liver parenchyma, which was a result of delayed liver shrinkage 2 years after TIPSS. The initial TIPSS procedure had been carried out in a 52-year-old man as a bridge for liver transplantation because of post-alcoholic liver cirrhosis. We describe the applied TIPSS recanalization and revision technique. Immediately after TIPSS revision acute liver failure developed, which required emergency liver transplantation.
- 24 August 2006
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 30 (1) , 129-132
Pseudoaneurysms of the Common Hepatic Artery Following Pancreaticoduodenectomy: Successful Emergency Embolization
We report a rare case of two communicating pseudoaneurysms of the common hepatic artery 1 month postoperatively following pylorus-preserving pancreaticoduodenectomy due an abscess formation. We describe the superselective transcatheteral embolization technique with deployment of interlocking detachable coils and Histoacryl-Lipiodol in this case and discuss the recent literature. Despite the technical success by achieving hemodynamic stability with initial preservation of liver function, the patient died 23 days postembolization due to multiorgan failure.
- 24 August 2006
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 30 (1) , 129-132
Pseudoaneurysms of the Common Hepatic Artery Following Pancreaticoduodenectomy: Successful Emergency Embolization
We report a rare case of two communicating pseudoaneurysms of the common hepatic artery 1 month postoperatively following pylorus-preserving pancreaticoduodenectomy due an abscess formation. We describe the superselective transcatheteral embolization technique with deployment of interlocking detachable coils and Histoacryl-Lipiodol in this case and discuss the recent literature. Despite the technical success by achieving hemodynamic stability with initial preservation of liver function, the patient died 23 days postembolization due to multiorgan failure.